Advertisement

Topics

Regeneron’s Founder Speaks Out on U.S. System for Pricing Drugs

20:00 EDT 29 Jul 2018 | BioSpace

It’s pretty easy to complain about the price of drugs. Drug companies typically spend billions of dollars to develop a drug, and often spend billions of dollars to develop drugs that never get approved. But a surprising critic of the U.S. system of pricing drugs is Leonard Schleifer.

Original Article: Regeneron’s Founder Speaks Out on U.S. System for Pricing Drugs

NEXT ARTICLE

More From BioPortfolio on "Regeneron’s Founder Speaks Out on U.S. System for Pricing Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...